PL3048165T3 - Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu im - Google Patents
Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu imInfo
- Publication number
- PL3048165T3 PL3048165T3 PL14755102T PL14755102T PL3048165T3 PL 3048165 T3 PL3048165 T3 PL 3048165T3 PL 14755102 T PL14755102 T PL 14755102T PL 14755102 T PL14755102 T PL 14755102T PL 3048165 T3 PL3048165 T3 PL 3048165T3
- Authority
- PL
- Poland
- Prior art keywords
- obesity
- prevention
- treatment
- associated diseases
- bifidobacterium animalis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
- A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
- A23C11/106—Addition of, or treatment with, microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/60—Drinks from legumes, e.g. lupine drinks
- A23L11/65—Soy drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201331088A ES2526986B1 (es) | 2013-07-18 | 2013-07-18 | Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas |
| EP14755102.2A EP3048165B1 (en) | 2013-07-18 | 2014-07-17 | Novel strain of bifidobacterium animalis subsp. lactis cect 8145 and use thereof for the treatment and/or prevention of excess weight and obesity and associated diseases |
| PCT/ES2014/070579 WO2015007941A1 (es) | 2013-07-18 | 2014-07-17 | Nueva cepa de bifidobacterium animalis subsp. lactis cect 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3048165T3 true PL3048165T3 (pl) | 2018-06-29 |
Family
ID=51392276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14755102T PL3048165T3 (pl) | 2013-07-18 | 2014-07-17 | Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu im |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10946051B2 (pl) |
| EP (1) | EP3048165B1 (pl) |
| CN (1) | CN105849248B (pl) |
| AU (1) | AU2014291922B2 (pl) |
| CA (1) | CA2918430C (pl) |
| CY (1) | CY1119770T1 (pl) |
| DK (1) | DK3048165T3 (pl) |
| ES (2) | ES2526986B1 (pl) |
| HR (1) | HRP20180053T1 (pl) |
| HU (1) | HUE035501T2 (pl) |
| LT (1) | LT3048165T (pl) |
| MX (1) | MX367132B (pl) |
| NO (1) | NO3048165T3 (pl) |
| PL (1) | PL3048165T3 (pl) |
| PT (1) | PT3048165T (pl) |
| RS (1) | RS56826B1 (pl) |
| SI (1) | SI3048165T1 (pl) |
| SM (1) | SMT201800072T1 (pl) |
| WO (1) | WO2015007941A1 (pl) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105002130A (zh) * | 2015-07-30 | 2015-10-28 | 江南大学 | 一种产胆盐水解酶的基因工程菌及其构建方法与应用 |
| EP3222282A1 (en) * | 2016-03-21 | 2017-09-27 | Bionou Research, S.L. | Use of probiotics in the treatment and/or prevention of psoriasis |
| CN105918460A (zh) * | 2016-04-11 | 2016-09-07 | 西南民族大学 | 一种益生菌谷物酸奶及其制备方法 |
| KR20220001516A (ko) * | 2016-04-14 | 2022-01-05 | 듀폰 뉴트리션 바이오사이언시즈 에이피에스 | 식품, 에너지 및/또는 지방 섭취 감소를 위한 비피더스균 |
| EP3272396A1 (en) * | 2016-07-18 | 2018-01-24 | Bionou Research, S.L. | Use of probiotics in the treatment and/or prevention of atopic dermatitis |
| IT201600091033A1 (it) * | 2016-09-08 | 2018-03-08 | Bioimmunizer Sagl | Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti. |
| CN109223833A (zh) * | 2017-07-10 | 2019-01-18 | 上海立龙生物科技有限公司 | 一种预防和改善肥胖的益生菌组合物 |
| EP3673044A1 (en) | 2017-08-25 | 2020-07-01 | University College Cork-National University of Ireland, Cork | Bifidobacterium longum for treating obesity and weight management |
| CN107699517A (zh) * | 2017-10-17 | 2018-02-16 | 无限极(中国)有限公司 | 一种青春双歧杆菌及其用途 |
| PL3489350T3 (pl) * | 2017-11-27 | 2022-01-24 | Ewelina Sosnowska-Turek | Szczep Bifidobacterium animalis AMT30 i kompozycja zawierająca szczep Bifidobacterium animalis AMT30 |
| EP3777868A4 (en) * | 2018-03-23 | 2021-12-01 | Morinaga Milk Industry Co., Ltd. | YOUNG CHILDREN'S COMPOSITION FOR THE PREVENTION OF HIGH BLOOD PRESSURE DISORDERS IN CHILDHOOD AND BEYOND |
| WO2019227414A1 (zh) * | 2018-05-31 | 2019-12-05 | 深圳华大生命科学研究院 | 一种组合物及其应用 |
| EP3812452A4 (en) | 2018-09-30 | 2021-11-03 | Inner Mongolia Yili Industrial Group Co., Ltd. | BIFIDOBACTERIUM LACTIS BL-99 AND ASSOCIATED APPLICATION |
| CN109182207B (zh) * | 2018-10-10 | 2020-10-27 | 北京首佳利华科技有限公司 | 一株具有调节血糖和胆固醇水平等益生功能的嗜酸乳杆菌La-SJLH001及其应用 |
| CN109749955B (zh) * | 2018-12-29 | 2020-08-21 | 浙江工业大学 | 短乳杆菌zj401及其应用 |
| CN109666615B (zh) * | 2019-02-20 | 2021-03-19 | 无限极(中国)有限公司 | 一种益生菌组合物及其应用 |
| US11045507B2 (en) | 2019-02-21 | 2021-06-29 | Ewelina Sosnowska-Turek | Bifidobacterium animalis AMT30 strain and the composition containing the strain of Bifidobacterium animalis AMT30 |
| EP4081225A1 (en) | 2019-12-27 | 2022-11-02 | Biopolis, S.L. | Uses of lipoteichoic acid from bifidobacteria |
| EP3851115A1 (en) * | 2020-01-15 | 2021-07-21 | Biopolis, S.L. | Probiotic composition for its use as an antioxidant |
| KR102136522B1 (ko) * | 2020-03-04 | 2020-07-22 | 주식회사 락토메이슨 | 안전성 및 장부착능이 우수한 모유유래 락토바실러스 루테리 lm1071 균주, 및 상기 균주 또는 이의 배양물을 포함하는 조성물 |
| CN111849836B (zh) * | 2020-08-08 | 2023-09-22 | 洪德轩 | 一种具有抗氧化的鼠李糖乳杆菌及其应用 |
| CN116076569B (zh) * | 2020-08-31 | 2025-05-13 | 内蒙古蒙牛乳业(集团)股份有限公司 | MN-Gup制备缓解肥胖或体重增加的乳制品中的用途 |
| EP4001399A1 (en) * | 2020-11-13 | 2022-05-25 | "NEOPHARM BULGARIA" Ltd. | Strain bifidobacterium animalis ssp. lactis dsm 33647 for modulating metabolism indicators |
| CN112618577B (zh) * | 2020-12-15 | 2023-07-25 | 深圳君拓生物科技有限公司 | 动物双歧杆菌在提高肿瘤免疫治疗应答中的作用 |
| CA3205469A1 (en) * | 2020-12-18 | 2022-06-23 | The General Hospital Corporation | Probiotics compositions and method of using the same to enhance growth and social function in children |
| CN112980719B (zh) * | 2020-12-30 | 2022-11-29 | 上海理工大学 | 一株耐氧动物双歧杆菌 |
| CN113005060B (zh) * | 2021-03-15 | 2022-11-01 | 江南大学 | 青春双歧杆菌ccfm1173在制备功能性菌剂、食品和或药物中的应用 |
| EP4387639A1 (en) * | 2021-08-19 | 2024-06-26 | Société des Produits Nestlé S.A. | Postbiotic |
| WO2023021141A1 (en) * | 2021-08-19 | 2023-02-23 | Société des Produits Nestlé S.A. | Postbiotic |
| CN114200120A (zh) * | 2021-12-02 | 2022-03-18 | 兰州大学 | 一种治疗肥胖症的药物筛选试剂盒及其使用方法 |
| CN114028444A (zh) * | 2021-12-03 | 2022-02-11 | 南京北极光生物科技有限公司 | 一种益生菌组合物及其在缓解抑郁症与减少脂堆积上的应用 |
| WO2023118868A1 (en) * | 2021-12-21 | 2023-06-29 | Quadram Institute Bioscience | Bifidobacterium and compositions thereof for breast cancer treatment |
| CN114317354B (zh) * | 2021-12-30 | 2024-05-07 | 美益添生物医药(武汉)有限公司 | 一种动物双歧杆菌及其培养方法和其在促进骨细胞生长和成熟中的应用 |
| CN114480229B (zh) * | 2022-04-15 | 2022-08-09 | 微康益生菌(苏州)股份有限公司 | 一种动物双歧杆菌乳亚种菌株wkb148及其产品与应用 |
| US20250205291A1 (en) | 2022-04-21 | 2025-06-26 | Abbott Laboratories | Methods and compositions for slowing diabetes development of reducing a risk of diabetes |
| CN114574407B (zh) * | 2022-05-06 | 2022-11-01 | 微康益生菌(苏州)股份有限公司 | 动物双歧杆菌乳亚种wkb99及其在制备改善代谢综合征制品方面的应用和产品 |
| CN114848683B (zh) * | 2022-05-09 | 2023-10-24 | 上海交通大学医学院附属瑞金医院 | 一种长双歧杆菌在制备预防或治疗多囊卵巢所致不孕症药物中的应用 |
| CN115181698B (zh) * | 2022-06-28 | 2023-09-08 | 广东粤港澳大湾区国家纳米科技创新研究院 | 一种益生菌组合物及应用 |
| CN116286551B (zh) * | 2023-04-25 | 2023-08-11 | 天赋能(天津)功能食品研究发展有限公司 | 长双歧杆菌婴儿亚种在调节体内脂肪代谢、塑形减脂改善肥胖方面的应用 |
| CN116622585A (zh) * | 2023-06-20 | 2023-08-22 | 广东南芯医疗科技有限公司 | 动物双歧杆菌乳亚种bl03在制备抗氧化和抗衰老产品中的应用 |
| WO2025008468A1 (en) * | 2023-07-04 | 2025-01-09 | Biopolis, S.L. | Bifidobacterium animalis subsp lactis strain cect 8145 and lta thereof health uses |
| CN116590205B (zh) * | 2023-07-14 | 2023-10-03 | 中国农业大学 | 一种动物双歧杆菌亚种组合菌剂在减肥制剂制备中的应用 |
| CN117448198B (zh) * | 2023-09-13 | 2025-03-11 | 杭州微致生物科技有限公司 | 一种动物双歧杆菌乳亚种vb301及其应用 |
| CN117025489B (zh) * | 2023-10-09 | 2024-03-19 | 杭州微致生物科技有限公司 | 一种动物双歧杆菌乳亚种vb315及其应用 |
| WO2025112480A1 (zh) * | 2023-11-30 | 2025-06-05 | 科郦有限公司 | 一种动物双歧杆菌乳亚种菌株、益生菌制剂及其制备方法和用途 |
| CN118240724B (zh) * | 2024-05-30 | 2024-08-16 | 内蒙古农业大学 | 一株动物双歧杆菌乳亚种ProSci-246及由其制备的产品和应用 |
| CN118902102A (zh) * | 2024-10-11 | 2024-11-08 | 浙江衡美健康科技股份有限公司 | 一种促进减脂的六重组合物及其制备方法和应用 |
| CN119174784B (zh) * | 2024-11-14 | 2025-03-04 | 华大精准营养(深圳)科技有限公司 | 动物双歧杆菌乳亚种或组合物在制备用于预防和/或治疗代谢性疾病的产品中的应用 |
| CN119709540B (zh) * | 2025-01-14 | 2026-03-27 | 天津大学浙江研究院(绍兴) | 假小链双歧杆菌及其应用 |
| CN119909105A (zh) * | 2025-04-02 | 2025-05-02 | 合生元(广州)健康产品有限公司 | 一种用于降脂降糖的营养组合物及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602006018627D1 (en) * | 2005-09-08 | 2011-01-13 | Yakult Honsha Kk | Cholesterol-absorptionsinhibitor |
| SE529185C2 (sv) * | 2005-10-07 | 2007-05-22 | Arla Foods Amba | Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt |
| US20110027348A1 (en) | 2007-08-27 | 2011-02-03 | Janos Feher | Composition and method inhibiting inflammation |
| CN104784220A (zh) * | 2009-06-19 | 2015-07-22 | 杜邦营养生物科学有限公司 | 治疗糖尿病及相关病症的双歧杆菌 |
| BR112012016861A2 (pt) * | 2010-01-08 | 2017-09-26 | Biopolis SL | "método para seleção de bactéria com ação antioxidante". |
| JP2011172506A (ja) * | 2010-02-24 | 2011-09-08 | Glico Dairy Products Co Ltd | プロバイオティクス用のビフィドバクテリウム・アニマリス・サブスピーシーズ・ラクティス菌株及びこれを用いたプロバイオティクス乳酸菌発酵食品又はその他のプロバイオティクス経口食品。 |
| JP2014508186A (ja) * | 2011-03-17 | 2014-04-03 | プロバイオティカル・ソシエタ・ペル・アチオニ | 抗酸化活性を有するプロバイオティクス細菌およびそれらの使用 |
-
2013
- 2013-07-18 ES ES201331088A patent/ES2526986B1/es active Active
-
2014
- 2014-07-17 DK DK14755102.2T patent/DK3048165T3/en active
- 2014-07-17 SI SI201430552T patent/SI3048165T1/en unknown
- 2014-07-17 HU HUE14755102A patent/HUE035501T2/en unknown
- 2014-07-17 WO PCT/ES2014/070579 patent/WO2015007941A1/es not_active Ceased
- 2014-07-17 NO NO14755102A patent/NO3048165T3/no unknown
- 2014-07-17 AU AU2014291922A patent/AU2014291922B2/en active Active
- 2014-07-17 ES ES14755102.2T patent/ES2655857T3/es active Active
- 2014-07-17 RS RS20180027A patent/RS56826B1/sr unknown
- 2014-07-17 MX MX2016000743A patent/MX367132B/es active IP Right Grant
- 2014-07-17 PL PL14755102T patent/PL3048165T3/pl unknown
- 2014-07-17 US US14/905,270 patent/US10946051B2/en active Active
- 2014-07-17 HR HRP20180053TT patent/HRP20180053T1/hr unknown
- 2014-07-17 CA CA2918430A patent/CA2918430C/en active Active
- 2014-07-17 SM SM20180072T patent/SMT201800072T1/it unknown
- 2014-07-17 CN CN201480040870.XA patent/CN105849248B/zh active Active
- 2014-07-17 PT PT147551022T patent/PT3048165T/pt unknown
- 2014-07-17 EP EP14755102.2A patent/EP3048165B1/en active Active
- 2014-07-17 LT LTEP14755102.2T patent/LT3048165T/lt unknown
-
2018
- 2018-01-10 CY CY20181100035T patent/CY1119770T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN105849248A (zh) | 2016-08-10 |
| EP3048165B1 (en) | 2017-10-11 |
| SMT201800072T1 (it) | 2018-03-08 |
| WO2015007941A1 (es) | 2015-01-22 |
| CA2918430C (en) | 2023-06-06 |
| AU2014291922B2 (en) | 2019-11-14 |
| PT3048165T (pt) | 2018-02-09 |
| RS56826B1 (sr) | 2018-04-30 |
| MX367132B (es) | 2019-08-05 |
| SI3048165T1 (en) | 2018-04-30 |
| EP3048165A1 (en) | 2016-07-27 |
| CY1119770T1 (el) | 2018-06-27 |
| CA2918430A1 (en) | 2015-01-22 |
| MX2016000743A (es) | 2016-07-14 |
| LT3048165T (lt) | 2018-03-12 |
| CN105849248B (zh) | 2020-05-05 |
| AU2014291922A1 (en) | 2016-02-25 |
| NO3048165T3 (pl) | 2018-03-10 |
| HK1226100B (en) | 2017-09-22 |
| US20160143963A1 (en) | 2016-05-26 |
| ES2526986A1 (es) | 2015-01-19 |
| HRP20180053T1 (hr) | 2018-03-23 |
| ES2526986B1 (es) | 2015-11-02 |
| US10946051B2 (en) | 2021-03-16 |
| HUE035501T2 (en) | 2018-05-02 |
| DK3048165T3 (en) | 2018-01-22 |
| ES2655857T3 (es) | 2018-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3048165T3 (pl) | Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu im | |
| IL265774B (en) | Diagnosis, prevention and treatment of joint diseases | |
| PT3554522T (pt) | Probióticos para utilização no tratamento de diverticulose e doença diverticular | |
| HUE060892T2 (hu) | Probiotikus baktériumtörzsek a szájüreg betegségeinek megelõzésére és kezelésére | |
| PL2990045T3 (pl) | Bifidobacterium animalis podgat. lactis do stosowania w zmniejszaniu bólu brzucha u kobiet po menopauzie | |
| DK2802333T3 (da) | Lactobacillus rhamnosus og Bifidobacterium animalis subsp. lactis til anvendelse til forebyggelse eller behandling af øvre luftvejsinfektioner | |
| SG11201504542PA (en) | Probiotic strains for the treatment and/or prevention of diarrhœa | |
| WO2015121458A3 (fr) | Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149 | |
| SMT202300225T1 (it) | Preparazione comprendente lactobacillus reuteri e citrato per uso medico | |
| IL238126A0 (en) | Compositions for the treatment and prevention of obesity | |
| MX2015005897A (es) | Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal. | |
| IL248935A0 (en) | Diagnostic testing and treatment/prevention of Alzheimer's disease | |
| PL3137097T3 (pl) | Leczenie i profilaktyka choroby Alzheimera (AD) | |
| ZA201607245B (en) | Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring | |
| PL3137094T3 (pl) | Leczenie i profilaktyka choroby alzheimera (ad) | |
| HUE057445T2 (hu) | Bifidobacterium animals AMT30 törzs és a Bifidobacterium animalis AMT30 törzset tartalmazó készítmények | |
| PL3137093T3 (pl) | Leczenie i profilaktyka choroby Alzheimera (AD) | |
| LT2914754T (lt) | Lactobacillus delbrueckii bakterijų nauja padermė ir jos panaudojimas bičių duonelės gamybai | |
| PT2922541T (pt) | Piridil-hidrazonas para o tratamento de tuberculose e doenças relacionadas | |
| GB201608841D0 (en) | Use of neurotoxin in the treatment of overweight, including obesity | |
| CN302205261S (zh) | 塑身裤 |